ThreeD Capital Inc. Releases Results For the Three Months Ended September 30, 2022

Written by Customer Service on November 28, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce its unaudited results as at and for the three months ended September 30, 2022. As at September 30, 2022, the Company had cash, investments and digital assets of $39.3 million. As at September 30, 2022, net asset value per share was $0.82 as compared to $1.06 as at June 30, 2022. (See “Use of Non-GAAP Financial Measures” elsewhere) Financial Highlights for the three months ending September 30, 2022 with comparatives: Operating Results Three months ended September 30, 2022 2021 Net investment and digital assets gains (losses) $ (10,430,815 ) $ 13,395,404 Operating,...

Marimaca Files Technical Report on Updated Mineral Resource Estimation

Written by Customer Service on November 28, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce that further to its news release dated October 13th, 2022 it has filed a technical report in accordance with Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”) on the Marimaca Copper Project titled “Updated Mineral Resource Estimation for the Marimaca Copper Project, Antofagasta Region, Chile”. The technical report is dated November 28, 2022 with an effective date of October 13th, 2022. The Technical Report is available under the Company’s profile on SEDAR at www.sedar.com. As a result of the completion of this Technical Report, the previous report titled “Preliminary Economic Assessment, Marimaca...

CE Brands Reports Second Quarter 2023 Financial Results and Restates First Quarter 2023 Financial Information

Written by Customer Service on November 28, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Nov. 28, 2022 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV: CEBI; CEBI.WT) (“CE Brands”, “we”, “our”, or the “Company”), a data-driven consumer-electronics company, today announced its financial results for the three and six-month period ended September 30, 2022 (“Q2 2023”) ⁽¹⁾. The related condensed interim consolidated financial statements and Management’s Discussion and Analysis (“MD&A”) for Q2 2023 are available on SEDAR at www.sedar.com and on CE Brands’ website at www.cebrands.ca/investors. Q2 2023 Highlights (Compared to Q2 2022) Revenue in the quarter increased 56% to $2.1 million driven by the launch of the moto watch 100. Gross profit improved 13% to $0.5 million. Increased investment, primarily in the marketing, selling and other costs to support revenue growth, netted a loss of $2.1 million, similar...

Liberty Gold Purchases Historic Black Pine Mine Water Rights, Securing an Additional Water Supply and Further De-Risking its Black Pine Oxide Gold Deposit, Idaho

Written by Customer Service on November 28, 2022. Posted in Public Companies.

Figure 1 Claims & Permitting Figure 2 Gravity-Vertical Derivative VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce that it has purchased and obtained registered title to two historical Black Pine Mine water rights totalling 868.5 acre feet per annum (“AFA”) (~1 million cubic meters per year “m3/yr”). Both rights are registered to the Black Pine Mine Well immediately adjacent to the potential site of a future heap leach pad. Liberty Gold has now secured, through a combination of purchase and long-term lease, an aggregate of 3,202 AFA (~4 million m3/yr) of process water supply, sufficient for any future large-scale mining operation envisioned at Black Pine. This final piece in the Company’s proactive, early-stage...

Brookfield Infrastructure Renews Its Normal Course Issuer Bids

Written by Customer Service on November 28, 2022. Posted in Public Companies.

BROOKFIELD, NEWS, Nov. 28, 2022 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (“BIP”) (NYSE: BIP; TSX: BIP.UN) today announced that the Toronto Stock Exchange (the “TSX”) accepted a notice filed by BIP of its intention to renew its normal course issuer bid for its outstanding limited partnership units (“LP Units”) and its class A preferred limited partnership units (“Preferred Units”, and together with LP Units, “Units”). Brookfield Infrastructure Corporation (“BIPC”) (NYSE/TSX: BIPC) also today announced that the TSX accepted a notice filed by BIPC of its intention to renew its normal course issuer bid for its outstanding class A exchangeable subordinate voting shares (“Exchangeable Shares”). BIP and BIPC believe that if the trading price of Units or Exchangeable Shares, respectively, does not fully reflect their...

CN Names Ed Harris Chief Operating Officer

Written by Customer Service on November 28, 2022. Posted in Public Companies.

MONTREAL, Nov. 28, 2022 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today announced the appointment of Edmond (Ed) Harris as Executive Vice-President and Chief Operating Officer. Mr. Harris succeeds Rob Reilly, effective immediately. Since April 2022, Mr. Harris, a highly respected industry veteran, has worked closely with the entire CN operations leadership team on the company’s operational and service excellence initiatives, as the team delivered meaningful rail operations performance and customer service improvements. “We are very pleased to be able to leverage Ed’s experience and capabilities as we continue to improve the delivery of safe and reliable freight transportation services to our customers. CN has made strides in improving our operational performance this year, and our team is ready and committed to take...

International Money Express, Inc. to Present at the UBS Global TMT Conference

Written by Customer Service on November 28, 2022. Posted in Public Companies.

MIAMI, Nov. 28, 2022 (GLOBE NEWSWIRE) — International Money Express, Inc. (NASDAQ: IMXI), (“Intermex” or the “Company”) a leading money remittance services company, today announced the Company will present at the UBS Global TMT Conference in New York City on Tuesday, December 6, 2022. The presentation will begin at 2:10 p.m. ET and will include comments from Andras Bende, chief financial officer. Investors and interested parties will be able to listen to the investor presentation via webcast at https://investors.intermexonline.com/news-events/events. The archived webcast will be available shortly after the conclusion of the presentation. About International Money Express, Inc.Founded in 1994, Intermex applies proprietary technology enabling consumers to send money from the United States and Canada to 18 countries in Latin America...

Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

Written by Customer Service on November 28, 2022. Posted in Public Companies.

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 54,498,889 common shares (“Common Shares”) at a price of CAD$0.027 per Common Share for aggregate gross proceeds of CAD$1,471,470 (or US$1,100,000) (the “Offering”). The net proceeds from the sale of the Common Shares will be used to: (i) add manufacturing capacities to extend the production of new cannabinoids isolates and high concentrated THC distillates; (ii) upgrade of the physical infrastructure of the extraction laboratory to comply with Q7A Good Manufacturing Practice guidelines for Active Pharmaceutical ingredients;...

Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System

Written by Customer Service on November 28, 2022. Posted in Mergers And Acquisitions.

Acquisition adds isotachophoresis (ITP), a proprietary technology licensed exclusively from Stanford University and developed by Purigen Biosystems for isolation and purification of nucleic acids, to the arsenal of tools for potentially simplifying ultra high molecular weight (UHMW) DNA isolation and purification for optical genome mapping (OGM) with more consistency at scale Adds the Ionic® Purification System, a commercially available platform for isolation of DNA and RNA from complex biological samples including those with low cell counts or otherwise challenging types such as formalin-fixed paraffin embedded (FFPE) tumor tissue, to Bionano’s portfolio of products Adds a world-class team with strong experience in developing, commercializing and supporting ITP-based systems for isolation and purification of biomolecules from a wide...

Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference

Written by Customer Service on November 28, 2022. Posted in Public Companies.

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Virtual Conference on November 30, 2022 at 10:30 a.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled...

Day: November 28, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice